- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/16 - Peri-condensed systems
Patent holdings for IPC class C07D 471/16
Total number of patents in this class: 453
10-year publication summary
|
28
|
24
|
38
|
46
|
33
|
33
|
37
|
45
|
39
|
17
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Intra-Cellular Therapies, Inc. | 435 |
100 |
| Merck Patent GmbH | 5725 |
28 |
| Genentech, Inc. | 4099 |
9 |
| Merck Sharp & Dohme LLC | 3735 |
8 |
| Glaxosmithkline Intellectual Property Development Limited | 776 |
7 |
| Merck Sharp & Dohme Corp. | 2183 |
6 |
| Universal Display Corporation | 2079 |
6 |
| UTi Limited Partnership | 459 |
6 |
| Glaxo Group Limited | 4370 |
5 |
| Samsung Display Co., Ltd. | 38570 |
5 |
| Abbvie Inc. | 1836 |
5 |
| Assia Chemical Industries Ltd. | 235 |
5 |
| Novartis AG | 10263 |
4 |
| Bristol-myers Squibb Company | 4729 |
4 |
| FUJIFILM Corporation | 30512 |
4 |
| Takeda Pharmaceutical Company Limited | 2715 |
4 |
| University of Florida Research Foundation, Inc. | 4173 |
4 |
| Actelion Pharmaceuticals Ltd | 497 |
4 |
| UDC Ireland Limited | 508 |
4 |
| Shanghaitech University | 390 |
4 |
| Other owners | 231 |